219 related articles for article (PubMed ID: 2098888)
1. [Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma].
Speranskiĭ AI; Riazantseva TA; Guseva NG; Melkumova KL; Ivanova SM
Revmatologiia (Mosk); 1990; (3):11-4. PubMed ID: 2098888
[TBL] [Abstract][Full Text] [Related]
2. [Scleroderma].
Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma.
Vlachoyiannopoulos PG; Boumba VA; Tzioufas AG; Seferiadis C; Tsolas O; Moutsopoulos HM
J Autoimmun; 1994 Apr; 7(2):193-201. PubMed ID: 8037838
[TBL] [Abstract][Full Text] [Related]
4. [Anticardiolipin antibodies in autoimmune rheumatic diseases].
Ergüven S; Calgüner M; Gülmezoğlu E; Sungur C; Ozcebe OI
Mikrobiyol Bul; 1989 Jan; 23(1):1-11. PubMed ID: 2696861
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to cardiolipin in stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus.
Chakravarty KK; Byron MA; Webley M; Durkin CJ; al-Hillawi AH; Bodley R; Wozniak J
Q J Med; 1991 May; 79(289):397-405. PubMed ID: 1924675
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against calpastatin in sera from patients with systemic sclerosis.
Sato S; Hasegawa M; Nagaoka T; Takamatsu Y; Yazawa N; Ihn H; Kikuchi K; Takehara K
J Rheumatol; 1998 Nov; 25(11):2135-9. PubMed ID: 9818655
[TBL] [Abstract][Full Text] [Related]
7. [The clinical significance of detecting the inhibition of topoisomerase I by the sera of patients with systemic scleroderma].
Shcherbakov AB; Remenson EI; Kirsanova ID; Basnak'ian AG; Guseva NG
Ter Arkh; 1992; 64(5):73-5. PubMed ID: 1333647
[TBL] [Abstract][Full Text] [Related]
8. Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome.
Marai I; Gilburd B; Blank M; Shoenfeld Y
Hum Antibodies; 2003; 12(3):57-62. PubMed ID: 14646033
[TBL] [Abstract][Full Text] [Related]
9. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
10. Localized scleroderma is an autoimmune disorder.
Takehara K; Sato S
Rheumatology (Oxford); 2005 Mar; 44(3):274-9. PubMed ID: 15561734
[TBL] [Abstract][Full Text] [Related]
11. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
12. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
13. [Progress in laboratory tests of connective tissue diseases].
Yamane K; Kato S; Sakauchi M
Rinsho Byori; 1989 Dec; 37(12):1311-6. PubMed ID: 2614963
[TBL] [Abstract][Full Text] [Related]
14. Localized scleroderma in childhood is not just a skin disease.
Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
16. [Anti-Scl-70 antibodies in systemic scleroderma].
Le Thi Huong ; Sauvaget F; Johanet C; De Gennes C; Raguin G; Abuaf N; Blétry O; Guillevin L; Homberg JC; Godeau P
Ann Dermatol Venereol; 1990; 117(2):103-7. PubMed ID: 2111650
[TBL] [Abstract][Full Text] [Related]
17. A common anti-cardiolipin antibody idiotype in autoimmune disease: identification using a mouse monoclonal antibody directed against a naturally-occurring anti-phospholipid antibody.
Sutjita M; Hohmann A; Comacchio R; Boey ML; Bradley J
Clin Exp Immunol; 1989 Feb; 75(2):211-6. PubMed ID: 2784733
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies in childhood scleroderma.
Bernstein RM; Pereira RS; Holden AJ; Black CM; Howard A; Ansell BM
Ann Rheum Dis; 1985 Aug; 44(8):503-6. PubMed ID: 3875322
[TBL] [Abstract][Full Text] [Related]
19. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease].
Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG
Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid antibodies in the connective tissue diseases: their relation to the antiphospholipid syndrome and forme fruste disease.
Buchanan RR; Wardlaw JR; Riglar AG; Littlejohn GO; Miller MH
J Rheumatol; 1989 Jun; 16(6):757-61. PubMed ID: 2778757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]